Bullish
GSK’s hepatitis B drug touts functional curative potential in double Phase III win
GSK and Ionis Pharmaceuticals' genetic medicine, bepirovirsen, showed functional curative potential in chronic hepatitis B (CHB) in two Phase III stud...